Clinical efficacy of selective anxiolytic compounds.
Département de Psychiatrie, Université de Sherbrooke, Québec, Canada.
J P
JP
Boulenger
J C
JC
Bisserbe
D014151:Anti-Anxiety Agents / Q000627:therapeutic use*; D001008:Anxiety Disorders / Q000188:drug therapy* / Q000523:psychology; D001569:Benzodiazepines; D006801:Humans; D011985:Receptors, Serotonin / Q000187:drug effects
D014151:Anti-Anxiety Agents; D011985:Receptors, Serotonin; D001569:Benzodiazepines